PRCT PROCEPT BioRobotics Corporation
$19.57▼ -1.31%
Healthcare
Other
Volume 12.7K
Avg Volume (10D) 1.14M
Key Metrics & Fundamentals
Market Cap
$1.11B
P/E Ratio
–
Div Yield
0.00%
52W Range
16.67 - 38.11
% vs 50 MA
1.63%
% vs 200 MA
-15.81%
RSI-14
56.4
MACD Histogram
+0.3000
Beta (1Y vs SPY)
0.72
Free Cash Flow
-$22.20M
Gross Rev
$94.50M
Gross Profit
$62.38M
EBITDA
-$23.94M
COGS
$32.12M
Operating Exp
$89.77M
Operating Income
-$27.39M
EBIT
-$27.39M
Pretax Income
-$26.77M
Net Income
-$26.86M
EPS (Diluted)
-0.47
Price & Volume History
Loading chart…
Recent News
PROCEPT BioRobotics (PRCT) Stock May Be Fully Priced On Cash Flow Hopes
Simply Wall St. · Oct 25, 2026 11:07 AM ET
PROCEPT BioRobotics® to Report Third Quarter 2026 Financial Results on November 4th, 2026
GlobeNewswire · Oct 12, 2026 4:05 PM ET
PROCEPT BioRobotics (PRCT) Could Be 70% Undervalued On Lawsuit And Board Change
Simply Wall St. · Oct 8, 2026 11:14 AM ET
Flutter upgraded, AppFolio downgraded: Wall Street's top analyst calls
The Fly · Oct 7, 2026 10:00 AM ET
Barclays Initiates PROCEPT BioRobotics at Overweight With $30 Price Target
MT Newswires · Oct 7, 2026 8:24 AM ET
Does New Director and Discounting Lawsuit Change The Bull Case For PROCEPT BioRobotics (PRCT)?
Simply Wall St. · Oct 6, 2026 1:07 PM ET
THINK Surgical Appoints Rick McDowell as Vice President, Sales
PR Newswire · Sep 22, 2026 10:46 AM ET
Procept BioRobotics CEO Buys 23,900 Shares Amid 48% Stock Decline. What Does This Tell Investors?
Motley Fool · Aug 18, 2026 6:31 PM ET
PROCEPT BioRobotics® to Attend the Baird 2026 Global Healthcare Conference on September 15, 2026
GlobeNewswire · Aug 17, 2026 8:00 AM ET
PROCEPT BioRobotics (PRCT) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 11, 2026 7:30 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See PRCT's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.